ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
0.005
0.00
(0.00%)
Closed January 24 3:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.005
Bid
0.005
Ask
0.01
Volume
5,000
0.005 Day's Range 0.005
0.005 52 Week Range 0.04
Market Cap
Previous Close
0.005
Open
0.005
Last Trade
5000
@
0.005
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
55,291
Shares Outstanding
132,634,000
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-0.02
Revenue
254k
Net Profit
-2.97M

About Aequus Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Vancouver, British Columbia, Can
Founded
-
Aequus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker AQS. The last closing price for Aequus Pharmaceuticals was $0.01. Over the last year, Aequus Pharmaceuticals shares have traded in a share price range of $ 0.005 to $ 0.04.

Aequus Pharmaceuticals currently has 132,634,000 shares outstanding. The market capitalization of Aequus Pharmaceuticals is $663,170 . Aequus Pharmaceuticals has a price to earnings ratio (PE ratio) of 0.00.

AQS Latest News

Aequus Reports Second Quarter 2023 Financial Highlights and General Update

VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus...

Aequus Announces Zimed PF Now Available in Canada

VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a specialty pharmaceutical company announced...

Aequus Announces Zimed PF Website Launch

VANCOUVER, British Columbia, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a specialty pharmaceutical company, are...

Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada

VANCOUVER, British Columbia, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a specialty pharmaceutical company announces...

Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)

VANCOUVER, British Columbia, July 06, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announces today it has increased its debt by...

Aequus Provides General Update and First Quarter 2023 Financial Highlights

VANCOUVER, British Columbia, May 30, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus...

Aequus Provides General Update and Fiscal 2022 Financial Results

VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on...

Aequus Grants Stock Options

VANCOUVER, British Columbia, April 19, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announces that it has granted incentive stock...

Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%) and Board Update

VANCOUVER, British Columbia, April 05, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announced today it has entered into a loan...

Aequus Announces Health Canada Notice of Compliance (NOC) for Zimed® Preservative Free (Bimatoprost 0.03%)

VANCOUVER, British Columbia, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), is pleased to announce that Health Canada has...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.0050.0050.005644500.005CS
4000.0050.0150.005820740.00882788CS
12-0.005-500.010.0150.005552910.00904611CS
26-0.025-83.33333333330.030.030.005571710.013502CS
52-0.02-800.0250.040.005859460.01951231CS
156-0.095-950.10.110.005673470.03266889CS
260-0.135-96.42857142860.140.290.0051154130.1221488CS

AQS - Frequently Asked Questions (FAQ)

What is the current Aequus Pharmaceuticals share price?
The current share price of Aequus Pharmaceuticals is $ 0.005
How many Aequus Pharmaceuticals shares are in issue?
Aequus Pharmaceuticals has 132,634,000 shares in issue
What is the market cap of Aequus Pharmaceuticals?
The market capitalisation of Aequus Pharmaceuticals is CAD 663.17k
What is the 1 year trading range for Aequus Pharmaceuticals share price?
Aequus Pharmaceuticals has traded in the range of $ 0.005 to $ 0.04 during the past year
What is the cash to sales ratio of Aequus Pharmaceuticals?
The cash to sales ratio of Aequus Pharmaceuticals is 0
What is the reporting currency for Aequus Pharmaceuticals?
Aequus Pharmaceuticals reports financial results in CAD
What is the latest annual turnover for Aequus Pharmaceuticals?
The latest annual turnover of Aequus Pharmaceuticals is CAD 254k
What is the latest annual profit for Aequus Pharmaceuticals?
The latest annual profit of Aequus Pharmaceuticals is CAD -2.97M
What is the registered address of Aequus Pharmaceuticals?
The registered address for Aequus Pharmaceuticals is SUITE 2600, 595 BURRARD STREET, VANCOUVER, BRITISH COLUMBIA, V7X 1L3
What is the Aequus Pharmaceuticals website address?
The website address for Aequus Pharmaceuticals is www.aequuspharma.ca
Which industry sector does Aequus Pharmaceuticals operate in?
Aequus Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PEXPacific Ridge Exploration Ltd
$ 0.18
(800.00%)
7.5k
RRM.HRoss River Minerals Inc
$ 0.045
(125.00%)
2k
MAHMarksmen Energy Inc
$ 0.01
(100.00%)
7k
MMNMonarca Minerals Inc
$ 0.01
(100.00%)
7.5k
JADEJade Leader Corp
$ 0.04
(100.00%)
88.63k
AGH.HCanadian Silver Hunter Inc
$ 0.015
(-62.50%)
1.31k
TVITVI Pacific Inc
$ 0.005
(-50.00%)
1.53M
MVYMoovly Media Inc
$ 0.005
(-50.00%)
1,000
GBUGabriel Resources Ltd
$ 0.005
(-50.00%)
394k
AJAAJA Health and Wellness Inc
$ 0.04
(-46.67%)
176.6k
TDGTDG Gold Corp
$ 0.455
(-6.19%)
6.45M
GPUSAlset AI Ventures Inc
$ 0.155
(-8.82%)
2.83M
FYLFinlay Minerals Ltd
$ 0.08
(6.67%)
2.81M
QNCQuantum Emotion Corp
$ 0.83
(-5.68%)
2.49M
ATXAtex Resources Inc
$ 1.86
(12.73%)
2.24M

Discussion

View Full Feed
luckydude777 luckydude777 2 minutes ago
ACON liftoff
ACON
CashCowMoo CashCowMoo 5 minutes ago
Yeah, doesnt look like they were really doing much. Look like they had some land but not major helium production.
RHCCF
Fiberrevo9 Fiberrevo9 6 minutes ago
Considering yesterday's trading session, the different trades, the rising pps, i am convinced that good news will be released next week.
What reassures me too is that, during last week, we had three times a peak to about 0,098, down manipulated as always, to a lower end pps, but more buys an
KBLB
gdog gdog 6 minutes ago
done
NLST
tw0122 tw0122 11 minutes ago
.05 + 15% 3m traded
ACON
Seminole Red Seminole Red 14 minutes ago
Constitutional amendment to allow Trump third term introduced in the House

A Republican House member introduced a resolution to amend the U.S. Constitution to allow President Donald Trump — and any other future president — to be elected to serve a third term.
Rep. Andy Ogles of
Guido2 Guido2 15 minutes ago
Goa. I was born here.
FNMA
MagnetLover MagnetLover 17 minutes ago
No way. Or else he would be too busy Sam Altmanning himself.
FLCX
Peter J Peter J 20 minutes ago
It took .000774 to buy those 774 shares todays. Who does this?Very good Question, Badog. A VERY good question...

May I remind you that most of the times over the last years... it was exactly the other way around!

Now, who did/does this...? And why...?

ERHE
tw0122 tw0122 21 minutes ago
$7.51 still a little left for latecomers just cash it out now 
ALUR
10thMountain 10thMountain 25 minutes ago
Speaking of stair stepping…

https://stockcharts.com/c-sc/sc?s=FDCT&p=D&yr=1&mn=0&dy=0&i=t4669085127c&r=1737710215304
FDCT
RickNagra RickNagra 27 minutes ago
Which part of India are you in ?  I know the place very well.
FNMA
tw0122 tw0122 30 minutes ago
Flip back out .53 will revisit 
BTAI
Peter J Peter J 30 minutes ago
Ntephe and insiders are getting away with violating SEC filing and disclosure requirements, with refusing to hold annual shareholder meetings, and with paying themselves undisclosed amounts from undisclosed sources of revenue.

All very true, sounds like a stock I would like to follow
ERHE
RickNagra RickNagra 34 minutes ago
Oh wow.
DBMM
tw0122 tw0122 37 minutes ago
BTAI .49 on the move in some 
BTAI
Peter J Peter J 38 minutes ago
Couldn't use these shares as collateral to buy a rotisserie chicken at Costco.
Well... that firmly explains his obsession with ERHE... 🤣

The altruist gang has combined between 10 and 20 K ERHC posts...

Strategy, remember... all for the good cause! Don't
ERHE
joeycav11 joeycav11 45 minutes ago
Were so undervalued…
With this revenue a medium biotech company can buy us and multiply there balance sheet by 6 times easy.
Obviously company is not selling cheap
Shake up is coming in pharma dont miss it
Cell therapy is the panacea and proven cures like we possess is t
AMRN
Here Today Here Today 46 minutes ago
Another train of thought is that possibly those patients in the Cohorts 1 & 2 might have been talking to their family and friends about this new drug they are on and the results they are seeing so far causing those family and friends to start researching and looking into the company and drug and the
RNAZ
Ribo Ribo 46 minutes ago
$BDPT, Dominate the Mat with Xcellara!!!

https://x.com/BioadaptivesInc/status/1882612437301834189
BDPT
Ribo Ribo 46 minutes ago
$BDPT, The Science Behind Xcellera!!!

https://x.com/BioadaptivesInc/status/1882610070749581750
BDPT
eagle8 eagle8 48 minutes ago
Peter Davis
@peter_brit
·
2h
#dcvax $nwbo #gbm

GPT-4o (Poe) Analysis providing additional context to the Information Disclosure Statement added by $nwbo to their combination patent.

The patent applicant for 18/489,222 (related to "Combinatio
NWBO
Seminole Red Seminole Red 48 minutes ago
yay

Your Recent History

Delayed Upgrade Clock